Title : Epoetin alfa maintains ribavirin dose in HCV-infected patients: a prospective, double-blind, randomized controlled study.

Pub. Date : 2004 May

PMID : 15131791






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Epoetin alfa maintains ribavirin dose in HCV-infected patients: a prospective, double-blind, randomized controlled study. Ribavirin erythropoietin Homo sapiens
2 This study assessed whether epoetin alfa could maintain RBV dose, improve quality of life (QOL), and increase hemoglobin (Hb) in anemic HCV-infected patients. Ribavirin erythropoietin Homo sapiens
3 RESULTS: At the end of the DBP, RBV doses were maintained in 88% of patients receiving epoetin alfa vs. 60% of patients receiving placebo (P < 0.001). Ribavirin erythropoietin Homo sapiens
4 CONCLUSIONS: Epoetin alfa maintained RBV dose and improved QOL and Hb in anemic HCV-infected patients receiving combination therapy. Ribavirin erythropoietin Homo sapiens